SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gains on reporting 40% rise in Q2 net profit

30 Oct 2013 Evaluate

Lupin is currently trading at Rs 903.50, up by 14.60 points or 1.64% from its previous closing of Rs 888.90 on the BSE.

The scrip opened at Rs 895.25 and has touched a high and low of Rs 910.00 and Rs 895.00 respectively. So far 192505 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 946.35 on 11-Oct-2013 and a 52 week low of Rs 557.10 on 19-Nov-2012.

Last one week high and low of the scrip stood at Rs 925.00 and Rs 868.15 respectively. The current market cap of the company is Rs 40429.38 crore.

The promoters holding in the company stood at 46.78% while Institutions and Non-Institutions held 43.52% and 9.69% respectively.

Lupin has reported results for the second quarter ended September 30, 2013.

The company has reported 151.33% rise in its net profit at Rs 809.12 crore for the quarter as compared to Rs 321.94 crore for the same quarter in the previous year. Total income of the company has increased by 44.67% at Rs 2541.48 crore for quarter under review as compared to Rs  1756.70 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 39.84% in net profit after taxes & Minority Interest at Rs 406.18 crore as compared to Rs 290.46 crore in the same quarter previous year. Total income of the group rose 19.27% to Rs 2749.23 crore for quarter under review as against Rs 2305.00 crore in corresponding quarter previous year.

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×